Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
131.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (0.152%)
Market Cap: £268.84m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

25 May 2016 11:20

RNS Number : 2785Z
Forterra plc
25 May 2016
 

25 May 2016

 

 

Forterra plc

 

Director / PDMR Shareholdings

 

Forterra plc (the "Company") was notified on 25 May 2016 that the following directors of the Company and persons discharging managerial responsibility ("PDMRs") in the Company were each awarded 277 ordinary shares of £0.01 each in the capital of the Company (the "Ordinary Shares") at no cost on 25 May 2016 in accordance with the terms of the Company's Share Incentive Plan.

Directors:Stephen HarrisonShatish Dasani

PDMRs:Matthew ClayBen GuyattAdam SmithGeorge Stewart

The above notification is intended to satisfy the Company's obligations under paragraph 3.1.4R of the Disclosure Rules and Transparency Rules.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

Benjamin Guyatt (Company Secretary)

FTI Consulting (public relations adviser to Forterra):

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

Forterra plc

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUPGAUPQGUA
Date   Source Headline
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20225:14 pmRNSGrant under Performance Share Plan
17th Mar 20224:53 pmRNSGrant under Deferred Annual Bonus Plan
17th Mar 20224:51 pmRNSGrant under Deferred Annual Bonus Plan
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
14th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20224:32 pmRNSEmployee Benefit Trust Share Purchase
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:00 pmRNSTotal Voting Rights
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.